# A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women

> **NCT00803686** · PHASE2 · COMPLETED · sponsor: **Tarsa Therapeutics, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Phase 1 Pharmacodynamic Study

## Interventions

- **DRUG:** Oral rsCT tablet
- **DRUG:** Oral Placebo Tablet
- **DRUG:** Oral rsCT tablet
- **DRUG:** Fortical (rsCT) nasal spray

## Key facts

- **NCT ID:** NCT00803686
- **Lead sponsor:** Tarsa Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00803686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00803686, "A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00803686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*